ANEMIA OF CHRONIC RENAL DISEASE

Course overview

ANEMIA OF CHRONIC RENAL DISEASE, ALSO KNOWN AS ANEMIA OF CHRONIC KIDNEY DISEASE (CKD), IS A FORM OF NORMOCYTIC, NORMOCHROMIC, HYPOPROLIFERATIVE ANEMIA. IT IS FREQUENTLY ASSOCIATED WITH POOR OUTCOMES IN CHRONIC KIDNEY DISEASE AND CONFERS AN INCREASED MORTALITY RISK. TREATMENT IS DIRECTED TOWARD IMPROVING RENAL FUNCTION, WHEN POSSIBLE, AND INCREASING RED BLOOD CELL PRODUCTION. ERYTHROPOIESIS-STIMULATING AGENTS, TOGETHER WITH IRON SUPPLEMENTATION, CONSTITUTE THE TREATMENT OF CHOICE FOR ANEMIA OF CHRONIC RENAL DISEASE. THIS ACTIVITY REVIEWS THE EVALUATION AND MANAGEMENT OF THE ANEMIA OF CHRONIC RENAL DISEASE AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE CARE OF INDIVIDUALS AFFECTED BY THIS CONDITION.